Turing Pharmaceuticals has been saying for a while now that it would lower the price of its toxoplasmosis med, Daraprim, responding to growing backlash from lawmakers and the public after it bought ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback